CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 AZUCAR BLANCA 110-C 40 mg/g
OCTINOXATE, ZINC OXIDE · EMULSION · BEL STAR S A
CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 AZUCAR BLANCA 110-C is a emulsion containing octinoxate, zinc oxide at 40 mg/g, taken topical. Manufactured by BEL STAR S A.
Key Facts
- Brand Name
- CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 AZUCAR BLANCA 110-C
- Generic Name
- OCTINOXATE, ZINC OXIDE
- NDC Code (Product)
14141-023- Manufacturer
- BEL STAR S A
- Strength
- 40 mg/g
- Dosage Form
- EMULSION
- Route
- TOPICAL
- Marketing Status
- Application #
- M020
- Marketing Start
- 04/13/2022
Recall History
No Recall HistoryFull Prescribing Information
Indications & Usage
Uses Helps prevent sunburn.
Dosage & Administration
Directions Apply liberally and evenly 15 minutes before sun exposure. Reapply at least every 2 hours. Use a water resistant sunscreen if swimming or sweating. Children under 6 months of age: Ask a doctor.
Warnings
Warnings Skin Cancer/Skin Aging Alert : Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to help prevent sunburn, not skin cancer or early skin aging. For external use only. Do not use on damaged or broken skin. When using this product keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if rash occurs. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Frequently Asked Questions
What is CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 AZUCAR BLANCA 110-C used for?
CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 AZUCAR BLANCA 110-C contains OCTINOXATE, ZINC OXIDE. It is a emulsion taken topical. Consult your doctor for specific uses.
Is CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 AZUCAR BLANCA 110-C a controlled substance?
CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 AZUCAR BLANCA 110-C is not classified as a controlled substance by the DEA.
What is the generic name for CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 AZUCAR BLANCA 110-C?
The generic name for CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 AZUCAR BLANCA 110-C is OCTINOXATE, ZINC OXIDE. There are 11 other brand versions of OCTINOXATE, ZINC OXIDE.
What is the NDC code for CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 AZUCAR BLANCA 110-C 40 mg/g?
The NDC (National Drug Code) for CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 AZUCAR BLANCA 110-C 40 mg/g is 14141-023, listed by BEL STAR S A.
Other Octinoxate, Brands
See all →- MISSHA M Perfect Cover BB No.237.5 g/100mL13733-252
- CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 AZUCAR MORENO 300-N40 mg/g14141-035
- LBEL FOREVER HYDRA BASE HIDRATANTE DE LARGA DURACION FPS 15 HYDRATING LONGWEAR FOUNDATION SPF 15 BEIGE 220-C50 mg/mL14141-311
- LBEL FOREVER ULTRA MATTE BASE CONTROL BRILLO DE LARGA DURACION FPS 15 SHINE CONTROL LONGWEAR FOUNDATION SPF 15 CHAMPAGNE 170-N50 mg/mL14141-317
- LBEL FOREVER ULTRA MATTE BASE CONTROL BRILLO DE LARGA DURACION FPS 15 SHINE CONTROL LONGWEAR FOUNDATION SPF 15 CAPUCCINO 310-C50 mg/mL14141-320
- LBEL CONCENTRE BASE SERUM ANTIEDAD EFECTO LIFTING FPS 15 ANTI AGING LIFTING SERUM FOUNDATION SPF 15 CHAMPAGNE 170-N60 mg/mL14141-326
- LBEL SOLUTIONS PRO-HIALURON BASE SERUM CON EFECTO RELLENO DE ARRUGAS FPS 15 WRINKLE FILLER EFFECT SERUM FOUNDATION SPF 15 CHAMPAGNE 170-N45 mg/mL14141-333
- LBEL SOLUTIONS PRO-HIALURON BASE SERUM CON EFECTO RELLENO DE ARRUGAS FPS 15 WRINKLE FILLER EFFECT SERUM FOUNDATION SPF 15 CAPUCCINO 310-C45 mg/mL14141-337
- LBEL FOREVER MATTE BASE CONTROL BRILLO Y LARGA DURACION 48H FPS 15 CONTROL AND LONGWEAR FOUNDATION 48H SPF 15 CHAMPAGNE 170-N50 mg/g14141-341
- LBEL FOREVER HYDRA BASE HIDRATANTE DE LARGA DURACION FPS 15 HYDRATING LONGWEAR FOUNDATION SPF 15 CHAMPAGNE 170-N50 mg/g14141-346
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)